Furthermore, it also suggested that the alteration of ALDH1B1, ALDH2 and ALDH7A1 levels may be potential biomarkers for the curative effect evaluation of gypenoside against liver fibrosis. The gene discussed is ALDH7A1; the disease is Hepatic fibrosis.